GLP Watchdog

altRX vs Direct Meds

altRX has an open FDA warning letter dated June 8, 2026. Direct Meds has an open FDA warning letter dated September 9, 2025. On compounded tirzepatide injection, altRX costs $3,000 less a year at standing rates: $149 a month against $399 a month at Direct Meds. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Direct Meds

altRX logo

altRX

8.8/10

Direct Meds logo

Direct Meds

7.1/10

FDA warning letters
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
None named in our record
Lowest standing price
$89/moCompounded semaglutide injection
$249/moCompounded oral semaglutide
States
All 50 states
48 states and DC
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit altRX
Visit Direct Meds

Both altRX and Direct Meds are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (altRX 8.8, Direct Meds 7.1). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Direct Meds has an open FDA warning letter dated September 9, 2025.

  2. 02

    altRX names four pharmacies. Direct Meds names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, altRX costs $3,000 less a year at standing rates: $149 a month against $399 a month at Direct Meds. It is one of two products the two sell at comparable terms.

  4. 04

    Only altRX lists a price for brand-name semaglutide pen and brand-name tirzepatide pen. Only Direct Meds lists a price for compounded oral semaglutide and compounded oral tirzepatide.

  5. 05

    AltRX covers two states Direct Meds does not.

  6. 06

    altRX states you can cancel at any time; Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Direct Meds

Compounded semaglutide injection

$89/moLower

$1,068 a year

$297/mo

$3,564 a year

Compounded tirzepatide injection

$149/moLower

$1,788 a year

$399/mo

$4,788 a year

Brand-name semaglutide pen

$1,149/mo

$13,788 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,249/mo

$14,988 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$249/mo

$2,988 a year

Compounded oral tirzepatide
Not sold or not priced

$299/mo

$3,588 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
No
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
90-day supply shipped at once, remaining months billed every 30 days
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
No refunds for medication already received; $35 disposal fee on returns

Read off each seller’s own pages. altRX: September 28, 2026. Direct Meds: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
  • $2,496 a year less on compounded semaglutide injection
  • $3,000 a year less on compounded tirzepatide injection
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Direct Meds does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, June 8, 2026
Visit altRX

The case for Direct Meds

7.1/10
  • Sells compounded oral semaglutide and compounded oral tirzepatide, which altRX does not price
  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Minimum commitment before you can cancel
Visit Direct Meds

Scores

altRX 8.8 · Direct Meds 7.1 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
4.2

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
4.5

Accessibility10%

10.0A
vs
B
9.7

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Direct Meds: questions

altRX has an open FDA warning letter dated June 8, 2026. Direct Meds has an open FDA warning letter dated September 9, 2025. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Direct Meds names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
altRX, by $2,496 a year at standing rates. altRX: $89 a month, about $1,068 a year. Direct Meds: $297 a month, about $3,564 a year.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Direct Meds has a minimum term (90-day supply shipped at once, remaining months billed every 30 days).
Both altRX and Direct Meds are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (altRX 8.8, Direct Meds 7.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks